Tonix Pharmaceuticals Holding Corp.
TNXP | NASDAQ
$10.89
+$0.17 (+1.59%)
Sep 22, 2026, 11:50 AM ET · Market open
Market Data
Market Cap $170.89M
Enterprise Value $-4.07M
Beta 1.75
Average Volume 506.1K
Shares Outstanding (Diluted) 16.64M
Shares Change YoY 127.03%
Institutional Ownership 35.52%
Exchange NASDAQ
ISIN US8902608392
Price Performance
Price Change 1M -16.8%
Price Change 3M -10.4%
Price Change 6M -28.5%
Price Change YTD -35.2%
Price Change 1Y -60.0%
Price Change 3Y -99.6%
Price Change 5Y -100.0%
1M CAGR (ann.) -10.9%
1Y CAGR (ann.) -62.2%
5Y CAGR (ann.) -87.9%
All-Time CAGR -71.6%
Valuation
PE Ratio -0.81
Forward PE N/A
PEG Ratio -0.07
Forward PEG 0.03
PS Ratio 5.87
Forward PS 1.50
PB Ratio 0.77
P/FCF Ratio -1.08
P/Adj. FCF Ratio -1.03
P/OCF Ratio -1.15
EV/Sales -0.14
EV/EBIT 0.03
EV/EBITDA 0.03
EV/FCF 0.03
Earnings Yield -123.5%
FCF Yield -92.5%
Adj. FCF Yield -97.1%
Financial Health
Net Cash $176.23M
Total Debt $1.27M
Cash & Short-Term Investments $176.23M
Total Assets $254.09M
Current Ratio 6.61
Quick Ratio 6.61
Debt / Equity Ratio 0.01
Debt / EBITDA -0.01
Debt / FCF -0.01
OCF / Debt -120.28
Interest Coverage 0.00
Altman Z-Score -3.07
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 80.3%
Operating Profit Margin -568.4%
EBITDA Margin -541.4%
Net Profit Margin -548.6%
FCF Margin -543.3%
Adj. FCF Margin -570.2%
SBC / Revenue 20.7%
SBC Impact (per share) -5.0%
Returns
Return on Assets -62.8%
Return on Equity -69.0%
Return on Invested Capital -74.0%
Return on Capital Employed -74.1%
Return on Tangible Assets -62.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 48.6%
Revenue CAGR 5Y 66.2%
Revenue CAGR 10Y 46.4%
EPS CAGR 3Y 149.3%
EPS CAGR 5Y 78.9%
EPS CAGR 10Y 48.2%
FCF CAGR 3Y -41.1%
FCF CAGR 5Y 4.2%
FCF CAGR 10Y -16.9%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 7
EPS Growth Next 3Y 26.9%
Revenue Growth Next 3Y 108.6%
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$2.45
EPS Growth Est (next Q) -31.8%
Revenue Est (next Q) $15.87M
Revenue Growth Est (next Q) 382.4%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $27
Price Target Upside 151.9%
Cash Flow
Operating Cash Flow $-152.99M
Free Cash Flow $-158.11M
Adj. Free Cash Flow $-165.94M
FCF Per Share -$9.61
OCF Per Share -$9.30
OCF/S Ratio -531.6%
Income Statement
Revenue $29.1M
Gross Profit $23.35M
Operating Income $-165.43M
EBITDA $-157.56M
Net Income $-159.67M
EPS (Diluted) -$13.24
Revenue / Employee $204.94K
Profit / Employee $-1.12M
Employees 142
Add to Watchlist
Select watchlists to add or remove TNXP